Krista Davis - 19 Sep 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Signature
/s/ Krista Davis, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
19 Sep 2025
Net transactions value
-$98,040
Form type
4
Filing time
22 Sep 2025, 17:14:59 UTC
Previous filing
15 Sep 2025
Next filing
19 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Krista SVP, CHIEF HR OFFICER C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Krista Davis, by attorney-in-fact Meredith W. Cook 22 Sep 2025 0001946439

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $98,040 -1,000 -1.6% $98.04 60,186 19 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024.